Skip to content

    Recently Viewed


      A diverse group of people sitting down on chairs

      What are clinical trials?

      Behind every innovative medicine, treatment and therapy is a clinical trial. Here’s a closer look at how they work.

      Share Article
      share to

      A clinical trial is a research study that determines whether specific healthcare interventions—such as investigational therapies, medicines and treatments—are safe and effective. An equitable and diverse clinical trial is a critical step toward getting a medicine or treatment approved by regulatory agencies, such as the U.S. Food and Drug Administration.

      Before reaching the clinical trial stage, these investigational interventions may have already undergone other types of research and testing, depending on regulatory requirements, explains Rocio Lopez, Global Operations Head, Global Development, the Janssen Pharmaceutical Companies of Johnson & Johnson.
      To confirm that the investigational intervention will consistently work as designed, various clinical trials are completed, and data is collected and submitted for approval to be used in patients with the condition being studied. This is the clinical trial process:

      • Phase 1: Researchers test the investigational drug or treatment in a small group of people to learn about its safety, including how it is absorbed by the body, what dosage should be used and potential side effects.
      • Phase 2: The intervention is given to a larger group of people to better understand ongoing safety, whether it works for a particular disease and the best dose.
      • Phase 3: The intervention is given to an even larger group of people. The main objectives are studying safety and side effects in bigger populations, whether it works for a particular disease and how it compares to already existing standard therapies.

      In some cases there may be a fourth phase after the intervention is approved where researchers will study long-term risks, benefits and side effects during day-to-day use in the population.

      While these phases are standard protocol for clinical trials, the actual length of the study depends on the intervention itself, what the trial is evaluating and the end goal, adds Lopez.

      The Importance of Diverse and Inclusive Clinical Trials

      Often, participants find out about clinical trials from their doctor or patient advocacy organization. If a patient has a condition and there are no approved treatments for it or the available treatments are not proving effective, a clinical trial could be an option, explains Lopez.

      Recruiting participants from a variety of demographics is crucial to ensure research is representative of the incredibly diverse communities served.

      Yet “historically, most of the trials that have been conducted have produced data that underrepresents different demographics, such as Black and Hispanic patients,” says Kate Owen, Global Development Head, Janssen.

      That’s why Johnson & Johnson has made diversity, equity and inclusion a top priority when designing and conducting clinical trials. Additionally, the company also works to drive health equity through Our Race to Health Equity, which aspires to eliminate health inequities for people of color and eradicate racial and social injustice as a public health threat.

      “By incorporating diverse and inclusive practices into every stage of our clinical trial process, more patients will have the opportunity to participate in clinical trials,” says Owen. “Together, we are building a world where health equity is the norm.”

      Want to Learn More About Clinical Trials?

      Check out the Research Includes Me website for educational resources on the clinical trial process.

      More from Johnson & Johnson

      Health & wellness
      3D human heart anatomy illustrations

      Do you know what heart failure is? (Hint: It’s probably not what you think)

      For American Heart Month, learn about the advances Johnson & Johnson is making to help turn heart failure into heart recovery for the millions of adults in the U.S. living with the condition, which occurs when the heart muscle isn’t able to pump blood as well as it should.
      Two cardiac electrophysiologists performing a cardiac ablation procedure to treat AFib

      What is cardiac ablation?

      For American Heart Month, learn how Johnson & Johnson is innovating to help treat the millions of people who are living with atrial fibrillation and other conditions that cause an irregular heartbeat.
      Latest news
       Biomedical scientist Robert Langer headshot

      Biomedical scientist Robert Langer receives the 2023 Dr. Paul Janssen Award for Biomedical Research

      Each year, Johnson & Johnson honors a scientist currently working in academia, industry or a scientific institute who has made a significant contribution toward the improvement of public health.
      You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.